Antibiotics in exacerbations of COPD: Lessons from the past

European Respiratory Journal

Volumn 24, Issue 6, 2004, Pages 896-897

  Miravitlles, M ^a   Torres, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CEFUROXIME; CLARITHROMYCIN; CORTICOSTEROID; GEMIFLOXACIN; LEVOFLOXACIN; LONG ACTING DRUG; MOXIFLOXACIN; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIOTROPIUM BROMIDE;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG COST; DRUG USE; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; IN VITRO STUDY; LUNG FUNCTION; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPIROMETRY;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CLARITHROMYCIN; DISEASE PROGRESSION; HUMANS; OFLOXACIN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS;

EID: 10444274099     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00099004     Document Type: Editorial

References (20)

1. Miravitlles M, Torres A. No more equivalence trials for antibiotics in exacerbations of COPD, please. Chest 2004; 125: 811-813.
2. Miravitlles M, Zalacain R, Murio C, et al. Speed of recovery from acute exacerbations of COPD after treatment with antimicrobials: results of a two-year study. Clin Drug Invest 2003; 23: 439-450.
3. Llor C, Naberan K, Cots JM, Molina J, Miravitlles M. Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care centers. Int J Clin Pract 2004; (In press).
4. Balter MS, La Forge J, Low DE, Mandell L, Grossman RF. Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can Respir J 2003; 10: 3B-32B.
5. ALAT Work Group. Update to the Latin American Thoracic Society (ALAT) recommendations on infectious exacerbation of COPD. Arch Bronconeumol 2004; 40: 315-325.
6. Lode H, Eller J, Linnhoff A, Ioanas M, and the Evaluation of Therapy-Free Interval in COPD Patients Study Group. Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval. Eur Respir J 2004; 24: 947-953.
7. Miravitlles M, Espinosa C, Fernández-Laso E, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest 1999; 116: 40-46.
8. Bobadilla A, Guerra S, Sherrill D, Barbee R. How accurate is the self-reported diagnosis of chronic bronchitis? Chest 2002; 122: 1234-1239.
9. Anzueto A, Rizzo JA, Grossman RF. The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis. Clin Infect Dis 1999; 28: 1344-1345.
10. White AJ, Gompertz S, Bayley DL, et al. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax 2003; 58: 680-685.
11. Patel IS, Seemungal TAR, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57: 759-764.
12. Chodosh S, Schreurs A, Siami G, et al. Efficacy of oral ciprofloxacin versus clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. Clin Infect Dis 1998; 27: 730-738.
13. Wilson R, Allegra L, Huchon G, et al. Short and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 2004; 125: 953-964.
14. Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur Respir J 2002; 20: 9s-19s.
15. Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347: 465-471.
16. Wilson R, Schentag JJ, Ball P, Mandell L. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Clin Ther 2002; 24: 639-652.
17. Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
18. Allegra L, Grassi C, Grossi E, et al. Ruolo degli antibiotici nel trattamento delle riacutizzazioni della bronchite cronica: risultati di uno studio italiano multicentrico. Ital J Chest Dis 1991; 45: 138-148.
19. Allegra L, Blasi F, de Bernardi B, Cosentini R, Tarsia P. Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo-controlled randomized study. Pulm Pharmacol Ther 2001; 14: 149-155.
20. Miravitlles M. Designing future clinical trials for acute exacerbations of chronic bronchitis. In: Allegra L, Blasi F, eds. Mechanisms and management of COPD exacerbations. Milan, Springer-Verlag, 2000; pp. 88-99.